C A Ison

8.0k total citations
189 papers, 5.7k citations indexed

About

C A Ison is a scholar working on Microbiology, Physiology and Epidemiology. According to data from OpenAlex, C A Ison has authored 189 papers receiving a total of 5.7k indexed citations (citations by other indexed papers that have themselves been cited), including 164 papers in Microbiology, 78 papers in Physiology and 52 papers in Epidemiology. Recurrent topics in C A Ison's work include Reproductive tract infections research (143 papers), Bacterial Infections and Vaccines (84 papers) and Syphilis Diagnosis and Treatment (78 papers). C A Ison is often cited by papers focused on Reproductive tract infections research (143 papers), Bacterial Infections and Vaccines (84 papers) and Syphilis Diagnosis and Treatment (78 papers). C A Ison collaborates with scholars based in United Kingdom, South Africa and Sweden. C A Ison's co-authors include Sarah Alexander, Stephanie Chisholm, Iona M. C. Martin, Brian G. Spratt, Kevin Fenton, C S Easmon, Michelle Cole, David M. Aanensen, D Taylor‐Robinson and Magnus Unemo and has published in prestigious journals such as The Lancet, SHILAP Revista de lepidopterología and The Journal of Immunology.

In The Last Decade

C A Ison

184 papers receiving 5.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
C A Ison United Kingdom 38 4.4k 2.2k 1.6k 763 753 189 5.7k
Carol A. Spiegel United States 20 3.2k 0.7× 760 0.4× 2.3k 1.4× 645 0.8× 567 0.8× 44 4.6k
Margaret R. Hammerschlag United States 44 3.9k 0.9× 815 0.4× 3.7k 2.3× 815 1.1× 505 0.7× 219 6.9k
Monica M Lahra Australia 32 2.5k 0.6× 1.4k 0.6× 1.1k 0.7× 710 0.9× 379 0.5× 154 3.9k
John R. Papp United States 29 2.7k 0.6× 1.1k 0.5× 1.3k 0.8× 501 0.7× 941 1.2× 77 3.5k
Lori M. Newman United States 25 2.8k 0.6× 2.5k 1.1× 1.9k 1.2× 854 1.1× 1.2k 1.6× 61 5.5k
William L. H. Whittington United States 41 2.5k 0.6× 794 0.4× 1.4k 0.9× 472 0.6× 1.4k 1.9× 93 4.2k
Tania Crucitti Belgium 35 2.9k 0.7× 761 0.4× 2.1k 1.3× 524 0.7× 965 1.3× 130 4.4k
Jane Rowley Switzerland 19 2.7k 0.6× 1.7k 0.8× 1.4k 0.8× 606 0.8× 1.1k 1.4× 41 4.2k
Cécile Bébéar France 53 4.8k 1.1× 601 0.3× 3.8k 2.4× 604 0.8× 194 0.3× 311 7.9k
Jørgen Skov Jensen Denmark 63 9.2k 2.1× 2.1k 1.0× 4.5k 2.8× 1.2k 1.6× 592 0.8× 278 12.2k

Countries citing papers authored by C A Ison

Since Specialization
Citations

This map shows the geographic impact of C A Ison's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C A Ison with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C A Ison more than expected).

Fields of papers citing papers by C A Ison

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C A Ison. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C A Ison. The network helps show where C A Ison may publish in the future.

Co-authorship network of co-authors of C A Ison

This figure shows the co-authorship network connecting the top 25 collaborators of C A Ison. A scholar is included among the top collaborators of C A Ison based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C A Ison. C A Ison is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sultan, Binta, Paul Benn, Gabriel Schembri, et al.. (2020). Test of cure study: a feasibility study to estimate the time to test of cure (TOC) forNeisseria gonorrhoeaeandChlamydia trachomatisinfections. Sexually Transmitted Infections. 96(6). 402–407.
2.
Ross, Jonathan, Helen Fifer, Peter Muir, et al.. (2017). P012 Highlighting clinical need in diagnosing mycoplasma genitalium infection: use of a modified delphi approach to obtain a uk perspective. Sexually Transmitted Infections. 93(Suppl 1). A21.2–A21. 1 indexed citations
3.
Field, Nigel, Iain T R Kennedy, Stephen Duffell, et al.. (2014). Screening for gonorrhoea using samples collected through the English National Chlamydia Screening Programme and risk of false positives: a national survey of Local Authorities. BMJ Open. 4(10). e006067–e006067. 7 indexed citations
4.
Sullivan, AK, Neil Macdonald, Patrick French, et al.. (2014). Clinical predictors of rectal lymphogranuloma venereum infection: results from a multicentre case–control study in the UK. Sexually Transmitted Infections. 90(4). 269–274. 22 indexed citations
5.
Rönn, Minttu M., Gwenda Hughes, Peter J White, et al.. (2014). Characteristics of LGV repeaters: analysis of LGV surveillance data: Table 1. Sexually Transmitted Infections. 90(4). 275–278. 14 indexed citations
6.
Chisholm, Stephanie, Magnus Unemo, Nerteley Quaye, et al.. (2013). Molecular epidemiological typing within the European Gonococcal Antimicrobial Resistance Surveillance Programme reveals predominance of a multidrug-resistant clone. Eurosurveillance. 18(3). 103 indexed citations
7.
Chisholm, Stephanie, J. Dave, & C A Ison. (2010). High-Level Azithromycin Resistance Occurs in Neisseria gonorrhoeae as a Result of a Single Point Mutation in the 23S rRNA Genes. Antimicrobial Agents and Chemotherapy. 54(9). 3812–3816. 139 indexed citations
8.
Laar, M J van de & C A Ison. (2007). Europe-wide investigation to assess the presence of new variant of Chlamydia trachomatis in Europe. Weekly releases (1997–2007). 12(6). E070208.4–E070208.4. 5 indexed citations
9.
Ison, C A. (2006). GC NAATs: is the time right?. Sexually Transmitted Infections. 82(6). 515–515. 32 indexed citations
10.
Fenton, Kevin, C A Ison, Alan P. Johnson, et al.. (2003). Ciprofloxacin resistance in Neisseria gonorrhoeae in England and Wales in 2002. The Lancet. 361(9372). 1867–1869. 67 indexed citations
11.
Ward, Helen, C A Ison, Sophie Day, et al.. (2000). A prospective social and molecular investigation of gonococcal transmission. The Lancet. 356(9244). 1812–1817. 39 indexed citations
12.
Sotolongo, Franklin, et al.. (2000). Resultados preliminares de la evaluación de diferentResultados diferentes concentraciones de la suspensión bacteriana empleada como inóculo en el Ensayo bactericida de Sangre Total. SHILAP Revista de lepidopterología. 9(2). 14–18. 1 indexed citations
13.
Keane, F, C A Ison, & D Taylor‐Robinson. (1997). A longitudinal study of the vaginal flora during the menstrual cycle of healthy female volunteers. International Journal of STD & AIDS. 8(1_suppl). 10–10. 3 indexed citations
14.
Ison, C A, Robert S. Heyderman, Nigel Klein, Mark Peakman, & Michael Levin. (1995). Whole blood model of meningococcal bacteraemia—a method for exploring host-bacterial interactions. Microbial Pathogenesis. 18(2). 97–107. 32 indexed citations
15.
Brown, Tom, R C Ballard, & C A Ison. (1995). Specificity of the immune response to Haemophilus ducreyi. Microbial Pathogenesis. 19(1). 31–38. 4 indexed citations
16.
Gill, Martin J., et al.. (1994). Naturally occurring PIA/PIB hybrids ofNeisseria gonorrhoeae. FEMS Microbiology Letters. 119(1-2). 161–166. 13 indexed citations
17.
Köhl, Peter, C A Ison, Dan Danielsson, J S Knapp, & D Petzoldt. (1990). Current status of serotyping of Neisseria gonorrhoeae. European Journal of Epidemiology. 6(1). 91–95. 9 indexed citations
18.
Easmon, C S, et al.. (1984). Spectinomycin as initial treatment for gonorrhoea.. BMJ. 289(6451). 1032–1034. 25 indexed citations
19.
Ison, C A, et al.. (1983). Spectinomycin resistant gonococci.. BMJ. 287(6408). 1827–1829. 22 indexed citations
20.
Spencer, R.C., et al.. (1977). Which Neisseria?. Sexually Transmitted Infections. 53(6). 394–397. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026